GlassScriptPhysician profile
Sanjay T Bhat
NPI 1356322036
$4,501.99
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,151 · 2020: $411 · 2021: $711 · 2022: $770 · 2023: $333 · 2024: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $459.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,435.33 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $521.95 | 2019-2024 | Entyvio |
| Genzyme Corporation | $280.02 | 2022-2023 | |
| Gilead Sciences, INC. | $250.13 | 2019-2020 | |
| Shire North American Group INC | $223.69 | 2019 | |
| Allergan, INC. | $214.37 | 2019 | |
| Braintree Laboratories, INC. | $185.85 | 2019-2021 | |
| Pfizer INC. | $185.62 | 2019-2023 | |
| Janssen Scientific Affairs, LLC | $143.20 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $138.09 | 2021 | |
| Redhill Biopharma INC. | $118.86 | 2020-2022 | |
| Janssen Biotech, INC. | $118.51 | 2019-2024 | Stelara |
| Ironwood Pharmaceuticals, INC | $97.16 | 2019-2020 | |
| Roche Diagnostics Corporation | $87.21 | 2019 | |
| Qol Medical, LLC | $79.53 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $76.78 | 2019-2023 | Dificid |
| Celgene Corporation | $71.16 | 2021-2024 | Zeposia |
| Concordia Pharmaceuticals INC. | $60.74 | 2019 | |
| Evoke Pharma, INC. | $38.50 | 2020 | |
| Intercept Pharmaceuticals, INC. | $35.19 | 2020-2024 | |
| Lilly USA, LLC | $24.85 | 2024 | Omvoh |
| Regeneron Healthcare Solutions, INC. | $24.36 | 2022 | |
| Organon LLC | $22.26 | 2023 | Hadlima, Renflexis |
| Nestle Healthcare Nutrition INC. | $17.94 | 2021 | |
| Ardelyx, INC. | $17.48 | 2024 | Ibsrela |
| Medtronic, INC. | $17.08 | 2022 | |
| Alfasigma USA, INC. | $16.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjay Bhat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.